Twist Bioscience (TWST) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and Twist Bioscience (NASDAQ:TWST) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, community ranking, valuation, institutional ownership, analyst recommendations and media sentiment.

Does the MarketBeat Community favor ASND or TWST?

Ascendis Pharma A/S received 342 more outperform votes than Twist Bioscience when rated by MarketBeat users. Likewise, 66.82% of users gave Ascendis Pharma A/S an outperform vote while only 58.99% of users gave Twist Bioscience an outperform vote.

Company	Underperform	Outperform
Ascendis Pharma A/S	Outperform Votes 447 66.82%	Underperform Votes 222 33.18%
Twist Bioscience	Outperform Votes 105 58.99%	Underperform Votes 73 41.01%

Is ASND or TWST more profitable?

Twist Bioscience has a net margin of -59.76% compared to Ascendis Pharma A/S's net margin of -104.54%. Ascendis Pharma A/S's return on equity of 0.00% beat Twist Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-104.54%	N/A	-39.23%
Twist Bioscience	-59.76%	-32.69%	-25.25%

Which has more volatility and risk, ASND or TWST?

Ascendis Pharma A/S has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500.

Does the media refer more to ASND or TWST?

In the previous week, Ascendis Pharma A/S had 1 more articles in the media than Twist Bioscience. MarketBeat recorded 11 mentions for Ascendis Pharma A/S and 10 mentions for Twist Bioscience. Ascendis Pharma A/S's average media sentiment score of 1.50 beat Twist Bioscience's score of 0.97 indicating that Ascendis Pharma A/S is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Twist Bioscience	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation & earnings, ASND or TWST?

Twist Bioscience has lower revenue, but higher earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$363.64M	25.81	-$409.12M	-$7.10	-21.68
Twist Bioscience	$330.19M	7.05	-$208.73M	-$3.38	-11.54

Do analysts prefer ASND or TWST?

Ascendis Pharma A/S currently has a consensus price target of $204.64, suggesting a potential upside of 32.95%. Twist Bioscience has a consensus price target of $52.80, suggesting a potential upside of 35.35%. Given Twist Bioscience's higher possible upside, analysts plainly believe Twist Bioscience is more favorable than Ascendis Pharma A/S.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.93
Twist Bioscience	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Summary

Ascendis Pharma A/S beats Twist Bioscience on 9 of the 16 factors compared between the two stocks.